Ascendis Pharma (ASND) PT Raised to $163 at Citi
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $246.23 -3.61%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Citi analyst David Lebowitz raised the price target on Ascendis Pharma (NASDAQ: ASND) to $163.00 (from $157.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
- Cellebrite (CLBT) PT Lowered to $15 at TD Cowen
- Godrej Consumer Products Ltd. (GCPL:IN) PT Lowered to INR1,150 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
